Articles dans des revues avec comité de lecture (81)
  1. 13. Devos, T., Havelange, V., Theunissen, K., Meers, S., Benghiat, F., Gadisseur, A. P. A. A., Vanstraelen, G., Vellemans, H., Bailly, B., Granacher, N., Lewalle, P., De Becker, A., Van Eygen, K., Janssen, M., Triffet, A., Vrelust, I., Deeren, D., Mazure, D., Bekaert, J., Beck, M., & Selleslag, D. (2021). Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry. Annals of hematology. doi:10.1007/s00277-021-04507-x
  2. 14. Merimi, M., Lagneaux, L., Lombard, C. A., Moussa Agha, D., Bron, D., Lewalle, P., Meuleman, N., Najimi, M., Sokal, E. M., & Najar, M. (2021). Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules. Inflammation research. doi:10.1007/s00011-020-01428-9
  3. 15. Bouhtit, F., Najar, M., Moussa Agha, D., Melki, R., Najimi, M., Sadki, K., Boukhatem, N., Bron, D., Meuleman, N., Hamal, A., Lagneaux, L., Lewalle, P., & Merimi, M. (2021). New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways. Molecules (Print Archive Edition), 26(2), 410. doi:10.3390/molecules26020410
  4. 16. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Fayyad Kazan, H., Lagneaux, L., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction. Cells, 9(9). doi:10.3390/cells9092053
  5. 17. Moussa Agha, D., Rouas, R., Najar, M., Bouhtit, F., Naamane, N., Fayyad Kazan, H., Bron, D., Meuleman, N., Lewalle, P., & Merimi, M. (2020). Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs. International journal of molecular sciences, 21(19). doi:10.3390/ijms21197065
  6. 18. Buyl, K., Merimi, M., Rodrigues, R. M., Moussa Agha, D., Melki, R., Vanhaecke, T., Bron, D., Lewalle, P., Meuleman, N., Fahmi, H., Rogiers, V., Lagneaux, L., Kock, J. D., & Najar, M. (2020). The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells. Journal of Clinical Medicine, 9(3), 696. doi:10.3390/jcm9030696
  7. 19. Roex, G., Feys, T., Beguin, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2020). Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies: An update of the pivotal clinical trial data. Pharmaceutics, 12(2), 194. doi:10.3390/pharmaceutics12020194
  8. 20. Dholaria, B., Savani, B. B., Labopin, M., Luznik, L., Ruggeri, A., Mielke, S., Al Malki, M. M., Kongtim, P., Fuchs, E., Huang, X. J., Locatelli, F., Aversa, F., Castagna, L., Bacigalupo, A., Martelli, M., Blaise, D., Soussan, P. B., Arnault, Y., Handgretinger, R., Roy, D. C., O'Donnell, P., Bashey, A., Solomon, S., Romee, R., Lewalle, P., Gayoso, J., Maschan, M., Lazarus, H. H., Ballen, K., Giebel, S., Baron, F., Ciceri, F., Esteve, J., Gorin, N. C., Spyridonidis, A., Schmid, C., Ciurea, S. O., Nagler, A., & Mohty, M. (2020). Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: Consensus recommendations from the Acute Leukemia Working Party of the EBMT. Haematologica, 105(1), 47-58. doi:10.3324/haematol.2019.219790
  9. 21. Roy, D. C., Walker, I., Maertens, J., Lewalle, P., Olavarria, E., Selleslag, D., Lachance, S., Buyse, M., Wang, K., Rovers, J., Santi, I., Bonig, H., Sandler, A., Velthuis, J. H. L., & Mielke, S. (2020). ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia. Leukemia. doi:10.1038/s41375-020-0733-0
  10. 22. Spilleboudt, C., De Wilde, V., Lewalle, P., Cabanne, L., Leclerc, M., Beckerich, F., Bories, D., Cardoso, S., Soares, M. P., Vokaer, B., Hougardy, J.-M., Flamand, V., Racapé, J., Abramowicz, M., Maury, S., & Le Moine, A. (2020). Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease. Frontiers in immunology, 11, 579151. doi:10.3389/fimmu.2020.579151
  11. 23. Merimi, M., Lagneaux, L., Moussa Agha, D., Lewalle, P., Meuleman, N., Burny, A., Fahmi, H., & Najar, M. (2020). Mesenchymal Stem/Stromal Cells in Immunity and Disease: A Better Understanding for an Improved Use. Journal of Clinical Medicine, 9(5). doi:10.3390/jcm9051516
  12. 24. Devos, T., Verhoef, G. E. G., Steel, E., Mazure, D., Lewalle, P., Bron, D., Berneman, Z. N., Benghiat, F., Mineur, P., Theunissen, K., Zachée, P., Doyen, C., Put, N., Lejeune, M., Van Eygen, K., Havelange, V., Reusens, M., Pluymers, W., & Peeters, K. (2019). Interruption or Discontinuation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukaemia: A Retrospective Cohort Study (SPARKLE) in Belgium. Acta haematologica. doi:10.1159/000499329
    13. << Précédent 1 2 3 4 5 6 7 8 Suivant >>